
Pacific Biosciences of California Investor Relations Material
Latest events

Q2 2025
Pacific Biosciences of California
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pacific Biosciences of California Inc
Access all reports
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company’s single molecule real-time (SMRT™) Sequencing platform enables single molecule real-time detection of biological processes. Its SMRT Sequencing technology provides various applications, including de novo sequencing to assemble a genome from scratch; targeted sequencing to sample specific regions of interest; and epigenetic sequencing to study how environmental factors affect gene expression. It has collaboration with Cold Spring Harbor Laboratory to expand its efforts in developing third-generation DNA sequencing technology.
Key slides for Pacific Biosciences of California Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Pacific Biosciences of California Inc


Q2 2025
Pacific Biosciences of California Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
PACB
Country
🇺🇸 United States